Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of bevacizumab as a first-line treatment for metastatic breast cancer.
Manso L, Moreno F, Márquez R, Castelo B, Arcediano A, Arroyo M, Ballesteros AI, Calvo I, Echarri MJ, Enrech S, Gómez A, González Del Val R, López-Miranda E, Martín-Angulo M, Martínez-Jañez N, Olier C, Zamora P. Manso L, et al. Among authors: castelo b. Curr Oncol. 2015 Apr;22(2):e51-60. doi: 10.3747/co.22.2210. Curr Oncol. 2015. PMID: 25908921 Free PMC article.
Angiogenesis as a therapeutic target in urothelial carcinoma.
Pinto A, Redondo A, Zamora P, Castelo B, Espinosa E. Pinto A, et al. Among authors: castelo b. Anticancer Drugs. 2010 Nov;21(10):890-6. doi: 10.1097/CAD.0b013e32833e83b2. Anticancer Drugs. 2010. PMID: 20729712 Review.
Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel.
Mendiola M, Martínez-Marin V, Herranz J, Heredia V, Yébenes L, Zamora P, Castelo B, Pinto Á, Miguel M, Díaz E, Gámez A, Fresno JÁ, Ramírez de Molina A, Hardisson D, Espinosa E, Redondo A. Mendiola M, et al. Among authors: castelo b. Oncotarget. 2016 Apr 26;7(17):24217-27. doi: 10.18632/oncotarget.8128. Oncotarget. 2016. PMID: 26992213 Free PMC article.
Targeting the endothelin axis in prostate carcinoma.
Pinto A, Merino M, Zamora P, Redondo A, Castelo B, Espinosa E. Pinto A, et al. Among authors: castelo b. Tumour Biol. 2012 Apr;33(2):421-6. doi: 10.1007/s13277-011-0299-6. Epub 2011 Dec 29. Tumour Biol. 2012. PMID: 22203496 Review.
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy.
Sánchez-Barroso L, Apellaniz-Ruiz M, Gutiérrez-Gutiérrez G, Santos M, Roldán-Romero JM, Curras M, Remacha L, Calsina B, Calvo I, Sereno M, Merino M, García-Donas J, Castelo B, Guerra E, Letón R, Montero-Conde C, Cascón A, Inglada-Pérez L, Robledo M, Rodríguez-Antona C. Sánchez-Barroso L, et al. Among authors: castelo b. Oncologist. 2019 Aug;24(8):e784-e792. doi: 10.1634/theoncologist.2018-0418. Epub 2018 Nov 23. Oncologist. 2019. PMID: 30470691 Free PMC article.
Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy.
Apellániz-Ruiz M, Lee MY, Sánchez-Barroso L, Gutiérrez-Gutiérrez G, Calvo I, García-Estévez L, Sereno M, García-Donás J, Castelo B, Guerra E, Leandro-García LJ, Cascón A, Johansson I, Robledo M, Ingelman-Sundberg M, Rodríguez-Antona C. Apellániz-Ruiz M, et al. Among authors: castelo b. Clin Cancer Res. 2015 Jan 15;21(2):322-8. doi: 10.1158/1078-0432.CCR-14-1758. Epub 2014 Nov 14. Clin Cancer Res. 2015. PMID: 25398452
48 results